Skip to main content
Equibles

Legal & General Group Plc

Position in PGEN — Precigen, Inc.

CIK 764068 London, X0
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$729,873
+$244,661 QoQ
Shares Held
128,048
+2.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. PGEN ranks #121 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $729,873 128,048
2026-03-31 $485,212 125,378
2025-12-31 $614,287 146,959
2025-09-30 $53,646 16,306
2025-06-30 $23,451 16,515
2025-03-31 $16,267 10,918
2024-12-31 $12,228 10,918
2024-09-30 $10,372 10,918
2024-06-30 $17,250 10,918
2024-03-31 $15,831 10,918
2023-12-31 $14,630 10,918
2023-09-30 $18,016 12,688
2023-06-30 $14,591 12,688
2023-03-31 $24,603 23,211
2022-12-31 $65,203 42,897
2022-09-30 $90,941 42,897
2022-06-30 $94,451 70,487
2022-03-31 $134,427 63,710
2021-12-31 $236,363 63,710
2021-09-30 $317,238 63,575
2021-06-30 $296,959 45,546
2021-03-31 $297,282 43,147
2020-12-31 $288,098 28,245
2020-09-30 $98,857 28,245
2020-06-30 $155,707 31,204
2020-03-31 $105,317 30,976